Related Experiment Video
Updated: Jun 12, 2025
Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay
Published on: April 28, 2022
Targeting TEAD would be a potential strategy for scarless wound repair: A preliminary study
Ming-Yan Yang1, Hong-Yuan Quan2, Da-Lei Li1
1School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, No. 32 Qingquan Road, Laishan District, Yantai, Shandong 264005, China.
Researchers explored a new drug, VT107, targeting TEAD to prevent skin scarring. The study found VT107 effectively reduced scar formation by inhibiting fibroblast proliferation and collagen deposition, offering a promising anti-scarring strategy.
Area of Science:
- Regenerative Medicine
- Dermatology
- Molecular Biology
Background:
- Current strategies for preventing skin scarring remain limited despite extensive research.
- Inhibition of YAP (Yes-associated protein) has shown potential for scarless wound repair.
- Targeting YAP directly presents significant drugability challenges.
Purpose of the Study:
- To evaluate the therapeutic potential of VT107, a novel TEAD auto-palmitoylation inhibitor, in preventing scar formation.
- To investigate the efficacy of inhibiting TEAD (Transcriptional enhancer factor D and myocyte enhancer factor 2 transcription factor D) as an alternative to targeting YAP.
Main Methods:
- Utilized a cutaneous wound healing model to assess the effects of VT107.
- Analyzed key markers of scar formation, including fibroblast proliferation, collagen denaturation, and deposition.
- Quantified the expression levels of TGF-β1 (Transforming growth factor beta 1) and CTGF (Connective tissue growth factor).
Main Results:
- VT107 demonstrated a significant positive effect in preventing scar formation.
- Inhibition by VT107 led to reduced fibroblast proliferation and collagen denaturation.
- VT107 decreased the expression of TGF-β1 and CTGF, along with collagen deposition.
Conclusions:
- Inhibiting TEAD auto-palmitoylation with VT107 is a viable strategy for scar prevention.
- TEAD represents a promising molecular target for developing novel anti-scarring therapies.
- These findings offer new insights into regenerative approaches for wound healing and scar management.
